---
title: Whether a prostate operation leaves a man incontinent is partly decided before he reaches theatre
publication: Medical Insights Korea
section: news
category: Prostate
canonical_url: https://medicalinsightskorea.com/news/prostatectomy-continence-predictable-before-surgery
author: Andrew Cho
published: 2026-09-02T11:20:00+09:00
modified: 2026-09-02T11:20:00+09:00
content_type: reporting
license: Quotation permitted with attribution to Medical Insights Korea and a link to the canonical URL.
---

# Whether a prostate operation leaves a man incontinent is partly decided before he reaches theatre

Pooled data on 12,620 men finds age, urethral length and existing urinary symptoms predict continence after robotic prostatectomy. All three are measurable at the clinic visit where the decision is made.

## Answer

In a meta-analysis of 48 studies covering 12,620 men, urinary incontinence in the first three months after robot-assisted radical prostatectomy was independently predicted by age (odds ratio 1.04 per year), membranous urethral length (0.83 per millimetre), International Prostate Symptom Score (1.03 per point), body mass index and prostate volume, with age, urethral length and symptom score still predictive between three and twelve months.

## Key takeaways

- A meta-analysis of 48 studies and 12,620 men found that within three months of robot-assisted radical prostatectomy, incontinence was predicted by age (odds ratio 1.04 per year), membranous urethral length (0.83 per millimetre), International Prostate Symptom Score (1.03 per point), body mass index and prostate volume.
- Between three and twelve months, age (1.05 per year), membranous urethral length (0.81 per millimetre) and symptom score (1.023 per point) remained independent predictors.
- Membranous urethral length is measured on preoperative MRI, and a longer urethra was protective — the effect runs in the opposite direction to the other factors.
- A separate meta-analysis of 13 studies and 22,183 patients found NeuroSAFE, an intraoperative frozen-section technique for preserving nerves, associated with better erectile function (odds ratio 2.00), better continence recovery (1.36) and fewer positive surgical margins (0.73), with no difference in biochemical recurrence.
- The incontinence review's own quality assessment found a high risk of bias in study participation and confounding, and the NeuroSAFE review reported substantial heterogeneity with most non-randomised studies at serious risk of bias.

## Full article

Two articles published here this week reported what Korean prostate cancer data does and does not contain, and both ended at the same gap: neither dataset records continence or sexual function, which are the reasons the decision to operate is difficult in the first place.

That literature exists. It is not Korean, and what it establishes is narrower than a patient wants — but it is more useful than it first appears, because much of what it identifies can be measured before anyone consents to anything.

### What predicts incontinence

A meta-analysis pooled 48 studies covering 12,620 men who had robot-assisted radical prostatectomy, and asked which preoperative variables predicted leaking afterwards.

**Odds of urinary incontinence within three months of surgery**

| Factor | Odds ratio | 95% CI |
| --- | --- | --- |
| Age, per year | 1.04 | 1.03–1.05 |
| Membranous urethral length, per mm | 0.83 | 0.76–0.91 |
| IPSS symptom score, per point | 1.03 | 1.01–1.05 |
| Body mass index, per point | 1.019 | 1.000–1.039 |
| Prostate volume, per ml | 1.009 | 1.004–1.013 |

Between three and twelve months the list narrows to three: age (1.05 per year), membranous urethral length (0.81 per millimetre) and symptom score (1.023 per point).

**0.83 per mm** — odds of early incontinence per additional millimetre of membranous urethral length — a measurement taken on the MRI that is done before the operation anyway  
_Source: Huang H, Cai K, Journal of Robotic Surgery, 2025_

> **Why the urethral length matters most of these**  
> Age and body mass index are facts about a man that a conversation cannot change. Membranous urethral length is an anatomical measurement read off the staging MRI that has already been performed, and it is the one factor here that points the other way: longer is better. It converts an unknown into a number available at the moment the choice between surgery, radiotherapy and surveillance is being made.

### The technique that appears to help

Preserving the nerves that run alongside the prostate protects erections and, to a lesser degree, continence — but preserving them risks leaving cancer behind. NeuroSAFE addresses that trade by examining the removed prostate's surface under the microscope during the operation, so that a surgeon who has spared nerves can go back and remove more if the margin is involved.

A meta-analysis of 13 studies covering 22,183 patients, two of them randomised trials, reports the following against standard robotic prostatectomy.

**NeuroSAFE-guided versus standard robot-assisted radical prostatectomy**

| Outcome | Odds ratio | 95% CI |
| --- | --- | --- |
| Postoperative erectile function | 2.00 | 1.46–2.74 |
| Urinary continence recovery | 1.36 | 1.05–1.76 |
| Positive surgical margins | 0.73 | 0.59–0.89 |
| Biochemical recurrence | 0.81 | 0.43–1.56 |

Better function and fewer positive margins at once is an unusual result, since the two normally trade against each other. The recurrence interval — 0.43 to 1.56 — is wide enough to be uninformative in either direction, which is what a reader should take from it rather than reassurance.

### How much weight these numbers carry

Both reviews are unusually direct about their own limitations, and both statements belong with the figures rather than after them.

- The incontinence review's quality assessment found a high risk of bias in study participation and confounding across the studies it pooled.
- The NeuroSAFE review reports substantial heterogeneity for some outcomes and notes that most of its non-randomised studies carried a serious risk of bias, which limits causal inference.
- Eleven of the thirteen NeuroSAFE studies were observational, and surgeons who adopt a technique like this early are not a random sample of surgeons.

### What is still missing for a Korean reader

1. Neither review is Korean, and neither reports how often incontinence or erectile dysfunction occurs — only what makes them more or less likely. A man asking what his own chances are will not find the answer here.
2. Korea's national datasets record diagnosis, treatment and cost, not function. Until a Korean series reports patient-reported continence and sexual function at fixed intervals, the trade-off at the centre of this decision is undocumented in Korean practice.
3. The predictors describe robot-assisted prostatectomy. Whether they transfer to open surgery or to radiotherapy is not addressed.
4. Radiotherapy has its own functional profile, largely bowel and late urinary effects, and none of it appears in these two reviews.

> **The practical point that survives**  
> A man weighing surgery against surveillance is usually given a general figure or none at all. Three of the strongest predictors in this literature — his age, his existing urinary symptom score, and the length of his membranous urethra on an MRI already taken — are known before the conversation starts. Whether they are used in it is a question about practice rather than about evidence.

## Sources

- Huang H, Cai K. Prognostic factors for urinary incontinence after robot-assisted radical prostatectomy: a systematic review and meta-analysis. Journal of Robotic Surgery 2025;19(1):628. doi:10.1007/s11701-025-02803-6. PMID:40987992. https://doi.org/10.1007/s11701-025-02803-6
- Suartz CV, Micheleto JPC, Condotta BE, Schumacher LB, Galhardo KA, Azevedo MFD, et al. NeuroSAFE-guided robot-assisted radical prostatectomy versus standard RARP: systematic review and meta-analysis of comparative studies. Journal of Robotic Surgery 2026;20(1):496. doi:10.1007/s11701-026-03390-w. PMID:42126466. https://doi.org/10.1007/s11701-026-03390-w
- An MH, Kim C, Min K, Yi KH, Park RW, Jung M. Target trial emulation of survival outcomes for clinically localized prostate cancer treatments. Discover Oncology 2026;17(1):1208. doi:10.1007/s12672-026-05392-4. PMID:42286375. https://doi.org/10.1007/s12672-026-05392-4

## Citation

Andrew Cho (2026). "Whether a prostate operation leaves a man incontinent is partly decided before he reaches theatre". Medical Insights Korea. https://medicalinsightskorea.com/news/prostatectomy-continence-predictable-before-surgery

Retrieved from https://medicalinsightskorea.com/news/prostatectomy-continence-predictable-before-surgery